Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I. Aayishamma, E Haripriya, Abhishek Ghara(Unknown), Gurubasavaraja Swamy Purawarga Matada(Drug Discovery Laboratory (Norway)), Rohit Pal(Unknown), Ketan R Hosamani, Nimmagadda Venkata Satya Sai Aishwarya(Unknown), B V Manjushree, B. Kumaraswamy
Cited by 32
Related Papers
Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer
|Journal of Biomolecular Structure and Dynamics|2021|37
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
|Medicinal Chemistry Research|2021|35
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review
|Journal of Biomolecular Structure and Dynamics|2023|28
An updated literature on BRAF inhibitors (2018–2023)
|Molecular Diversity|2023|24
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review
|Inflammopharmacology|2021|21